PNC FINANCIAL SERVICES GROUP, INC. - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,324
+13.3%
160
+63.3%
0.00%
Q2 2023$2,052
-0.9%
980.0%0.00%
Q1 2023$2,070
-17.0%
980.0%0.00%
Q4 2022$2,494
+24.7%
980.0%0.00%
Q3 2022$2,0000.0%980.0%0.00%
Q2 2022$2,0000.0%980.0%0.00%
Q1 2022$2,0000.0%980.0%0.00%
Q4 2021$2,0000.0%980.0%0.00%
Q3 2021$2,0000.0%980.0%0.00%
Q2 2021$2,0000.0%980.0%0.00%
Q1 2021$2,000
+100.0%
98
-44.3%
0.00%
Q3 2018$1,0001760.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 8,076$174,5220.01%
MASSMUTUAL TRUST CO FSB/ADV 46$9940.00%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders